Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 362
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Completed
15 and over
Other
LAL-RI/96
NCT00494897
2.
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)(COMPLETED)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Completed
18 and over
Pharmaceutical / Industry
P04594
NCT00687011
3.
Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
25 to 65
DFCI-75116
Last Modified:
12/1/1989
4.
Phase II/III L-PAM/PRED/VCR vs VP-16/PRED/ADR for Stage II/III Myeloma (Summary Last Modified 12/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
20 and over
SAFR-CT-MM-2
Last Modified:
11/1/1988
5.
Phase II/III Pilot Study of Chemotherapy Consisting of Induction with VCR/ADR/ARA-C/6-MP/PRED Followed by Consolidation with CTX/ARA-C/6-MP and Maintenance with 6-MP/ARA-C/ADR in Children with AML (Summary Last Modified 11/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 20
ARG-GATLA-3LMA83
Last Modified:
5/1/2000
6.
Phase II/III Pilot Study of Combination Chemotherapy for Children with ALL in Relapse after Treatment on BFM Protocols (Summary Last Modified 05/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 20
ARG-GATLA-1LLAREC90
NCI-F92-0006, NCT00002499
7.
Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 and over
Other
GMALL06
NCT00199108
Last Modified:
12/29/2008
 
First Published:
1/1/1994
8.
NCI HIGH PRIORITY CLINICAL TRIAL --- Phase III Randomized Study of Melphalan/Total Body Irradiation with Peripheral Blood Stem Cell Rescue vs VBMCP (Vincristine/Carmustine/Melphalan/Cyclophosphamide/Prednisone) Following Standard Induction for Previously Untreated Symptomatic Multiple Myeloma, with Further Randomization for Major Responders to Interferon alfa vs Observation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
70 and under
NCI
SWOG-9321
CLB-9312, E-S9321, INT-0141, NCT00002548
Last Modified:
5/24/2006
9.
Phase III Randomized Study of Bone Marrow Transplantation vs Prolonged Intensive Chemotherapy Following Remission Re-Induction after Early First Marrow Relapse in Children with Acute Lymphocytic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
at least 1 + under 20 at diag.
NCI
CCG-1941
Last Modified:
8/1/1995
10.
Phase III Randomized Study of DepoFoam-Encapsulated Cytarabine (DTC 101) vs Standard Intrathecal Therapy for Neoplastic Meningitis (Summary Last Modified 08/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
any age
Pharmaceutical / Industry
MSKCC-94129
NCI-V95-0661
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute